Tramadol half life is dose dependent in overdose

Area of Science:

• Pharmacology and Toxicology
• Clinical Chemistry
• Emergency Medicine

Background:

• Tramadol overdose is a significant public health concern in Iran, leading to frequent emergency department admissions.
• Limited data exists on the toxicokinetic properties of Tramadol, particularly its half-life, hindering effective overdose management.
• Understanding Tramadol's half-life is crucial for developing evidence-based poisoning treatment strategies.

Purpose of the Study:

• To investigate and determine the half-life of Tramadol in individuals experiencing an overdose.
• To establish a critical toxicokinetic variable for managing Tramadol poisoning.
• To correlate Tramadol half-life with overdose severity and concentration.

Main Methods:

• Blood samples were collected from patients upon admission and at subsequent intervals.
• Plasma Tramadol concentrations were quantified using High-Performance Liquid Chromatography (HPLC).
• Calculations were performed to determine the elimination half-life based on serial blood concentrations.

Main Results:

• The study population comprised predominantly males (81.81%) with a mean age of 23 years.
• Mean initial and subsequent serum Tramadol concentrations were 786.91 and 433.09 ng/mL, respectively.
• The calculated mean Tramadol half-life in overdose was 9.24 hours, with a significant association found between longer half-life and higher initial concentrations (r=0.708).

Conclusions:

• The mean Tramadol half-life in overdose cases (9.24 hours) is substantially longer than previously reported in pharmacokinetic studies.
• Tramadol half-life in overdose appears to be dose-dependent.
• The prolonged and dose-dependent half-life of Tramadol may contribute to the severe consequences observed in overdose patients.